Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Implantable medical devices].

B Crickx1, X Arrault

  • 1Université Denis-Diderot, Paris 7 et Service de Dermatologie, Groupe hospitalier Bichat-Claude-Bernard, AP-HP, 46 rue Henri Huchard, 75018 Paris, France. beatrice.crickx@bch.aphp.fr

Annales De Dermatologie Et De Venereologie
|May 6, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[25 years spent in the editorial board ofAnnales de dermatologie, including 6 as editor (2004-2009)].

Annales de dermatologie et de venereologie·2019
Same author

[Acute generalized exanthematous pustulosis induced by phloroglucinol].

Annales de dermatologie et de venereologie·2017
Same author

Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Dissecting cellulitis of the scalp: a retrospective study of 51 patients and review of literature.

The British journal of dermatology·2015
Same author

[Sirolimus-induced lymphedema in a kidney-transplant recipient: Partial recovery after changeover to tacrolimus].

Annales de dermatologie et de venereologie·2015
Same author

Drug reaction with eosinophilia and systemic symptoms, or virus reactivation with eosinophilia and systemic symptoms as a manifestation of immune reconstitution inflammatory syndrome in a patient with HIV?

The British journal of dermatology·2014
Same journal

2024 guidelines (S3) for the therapeutic management of patients with genital herpes.

Annales de dermatologie et de venereologie·2026
Same journal

Topical JAK inhibitors in the lichen planus spectrum: a systematic review.

Annales de dermatologie et de venereologie·2026
Same journal

2024 recommendations for the therapeutic management of anogenital warts.

Annales de dermatologie et de venereologie·2026
Same journal

Successful use of thalidomide in treating metastatic Crohn's disease.

Annales de dermatologie et de venereologie·2026
Same journal

Multiple cutaneous juvenile xanthogranuloma: a monocentric study.

Annales de dermatologie et de venereologie·2026
Same journal

Cartilage-hair-hypoplasia associated with granulomatosis induced by rubella vaccine.

Annales de dermatologie et de venereologie·2026
See all related articles

Implantable medical devices require clear identification and robust health traceability systems. These systems ensure patient safety by tracking device batches and monitoring outcomes, with data preserved for extended periods.

Area of Science:

  • Medical Device Regulation
  • Health Informatics
  • Patient Safety

Background:

  • Medical devices are categorized, including implantable devices defined by EU directives.
  • Clear identification of implantable medical devices (common and commercial names) is crucial.
  • Physician and user services must be clearly identified for accountability.

Purpose of the Study:

  • To outline the regulatory framework for implantable medical devices.
  • To emphasize the importance of health traceability for patient safety.
  • To define data preservation timelines for medical devices and patient records.

Main Methods:

  • Review of EU Directive 93/42/CEE and relevant decrees.
  • Analysis of requirements for implantable medical device identification.

Related Experiment Videos

  • Examination of health traceability protocols and data retention policies.

    • Main Results:

    • Implantable medical devices necessitate specific identification (common/commercial names, model details).
    • Health traceability rules are established to rapidly identify at-risk patients and monitor consequences.
    • Traceability data requires 10-year preservation, with patient medical files retained for 20 years.

    Conclusions:

    • Strict identification and traceability are essential for managing implantable medical device risks.
    • Long-term data preservation supports post-market surveillance and patient safety.
    • Regulatory compliance ensures accountability and effective risk management in healthcare.